Jun 30, 2026 07:43AM
May 12, 2026 07:43AM
Nov 18, 2025 07:51AM
Sep 15, 2025 08:01AM
Sep 15, 2025 08:00AM
Jul 21, 2025 07:00AM
Nov 20, 2024 07:00AM Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025
Jul 11, 2024 07:00AM
Jun 27, 2024 06:30PM
Jun 14, 2024 07:02AM
Jun 14, 2024 07:00AM
May 15, 2024 07:00AM
Mar 14, 2024 07:00AM
Jan 10, 2024 07:00AM New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
Oct 6, 2023 07:00AM
Sep 28, 2023 07:00AM
Sep 7, 2023 07:00AM
Jul 21, 2023 07:01AM
Jul 21, 2023 07:00AM
Jun 29, 2023 06:01PM
Jun 9, 2023 07:00AM Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
Apr 19, 2023 07:00AM
Apr 12, 2023 07:00AM
Mar 30, 2023 07:00AM
Feb 8, 2023 07:00AM
Jan 26, 2023 07:00AM
Jan 9, 2023 07:00AM
Dec 1, 2022 07:00AM Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes
Nov 30, 2022 07:00AM
Nov 29, 2022 07:00AM
Nov 22, 2022 07:00AM
Nov 3, 2022 07:00AM
Oct 31, 2022 07:00AM
Oct 24, 2022 07:00AM
Oct 17, 2022 07:00AM KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Sep 20, 2022 07:00AM
Aug 8, 2022 07:00AM
Jun 30, 2022 07:00AM
Jun 23, 2022 07:00AM
Jun 10, 2022 07:06AM
Jun 10, 2022 07:00AM
Jun 6, 2022 07:00AM KidneyIntelX™ Demonstrates Ability to Assess Risk of Heart Failure Hospitalization and Death in Large International Diabetic Kidney Disease Patient Cohort
Jun 2, 2022 07:00AM
Apr 8, 2022 07:00AM
Apr 8, 2022 07:00AM
Mar 31, 2022 07:05AM
Mar 31, 2022 07:00AM
Mar 30, 2022 07:00AM
Mar 29, 2022 07:00AM Renalytix Reaches Enrollment Milestone for Building KidneyIntelX as Premier Precision Medicine Platform for Kidney Disease and Diabetes
Mar 25, 2022 07:00AM

325,294 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All